Access cutting-edge pneumonia treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access pneumonia specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumonia treatment provided free
The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20 in infants at 2, 4, 6, and 12-15 months of age, in addition to receiving routine US concomitant vaccines. Stage 1 of the study will comprise 3 dose ascending cohorts. Stage 2 of the study will enroll approximately 352 subjects. Stage 3 of the study will enroll approximately 500 subjects.
Sponsor: Vaxcyte, Inc.
Check if you qualify for this pneumonia clinical trial in Aurora, CO
If you're searching for pneumonia treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumonia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.